Scientists interested in cannabis as a subject for pharmaceutical studies may find an unlikely new home for their research into the plant, its byproducts and biochemistry aboard the International Space Station. Yes, weed is going to space thanks to the work of a small Lexington, Ky.-based startup called Space Tango. The company makes a “clean […]
View More Weed in space is going to be a thing nowCategory: drug discovery
uBiome is jumping into therapeutics with a healthy $83 million in Series C financing
23andMe, IBM and now uBiome is the next tech company to jump into the lucrative multi-billion dollar drug discovery market. The company started out with a consumer gut health test to check whether your intestines carry the right kind of bacteria for healthy digestion but has since expanded to include over 250,000 samples for everything […]
View More uBiome is jumping into therapeutics with a healthy $83 million in Series C financingAs biological manufacturing moves to the mainstream, Synvitrobio rebrands and raises cash
The pace at which the scientific breakthroughs working to bend the machinery of life to the whims of manufacturing have transformed into real businesses has intensified competition in the biomanufacturing market. That’s just one reason why Synvitrobio is rebranding as it takes on $2.6 million in new financing to pursue opportunities in biopharmaceutical and biochemical manufacturing. […]
View More As biological manufacturing moves to the mainstream, Synvitrobio rebrands and raises cashImplantable 3D printed organs could be coming sooner than you think
At MBC Biolabs, an incubator for biotech startups in San Francisco’s Dogpatch neighborhood, a team of scientists and interns working for the small startup Prellis Biologics have just taken a big step on the path toward developing viable 3D printed organs for humans. The company, which was founded in 2016 by research scientists Melanie Matheu […]
View More Implantable 3D printed organs could be coming sooner than you thinkThe genomics-focused Illumina Accelerator backs five new companies
Illumina Accelerator, the genomics-focused startup accelerator backed by the publicly traded genetic sequencing pioneer Illumina Corp., has picked five startups for its seventh accelerator class, the company announced. Wth technology addressing skin microbial therapeutics, fertility science, chronic disease alleviation, post traumatic stress disorder treatments, and services for the biopharmaceutical and clinical research industries; the startups […]
View More The genomics-focused Illumina Accelerator backs five new companiesAtomwise, which uses AI to improve drug discovery, raises $45M Series A
Atomwise, which uses deep learning to shorten the process of discovering new drugs, has raised a $45 million Series A. The round was led by Monsanto Growth Ventures, Data Collective (DCVC) and B Capital Group. Baidu Ventures, Tencent and Dolby Fa…
View More Atomwise, which uses AI to improve drug discovery, raises $45M Series A